DIAGNOSTICOS DA AMÉRICA S.A. Publicly-Traded Company NIRE 35.300.172.507
CNPJ/MF n.º 61.486.650/0001-83
Diagnósticos da América S.A. ("Company" or "DASA"), in accordance with Law No 6.404, enacted on December 15, 1976, as amended, with article 2 of Comissão de Valores Mobiliários ("CVM") Instruction No 358, enacted on January 3, 2002, as amended, and in addition to the information in the material fact disclosed on April 27, 2015, and in the material facts disclosed thereafter, informs its shareholders and the market, in connection to the voluntary tender offer made by CROMOSSOMO PARTICIPAÇÕES II S.A. and detailed in the public note of tender offer of December 29, 2015 ("Tender Offer"), that the Board of Directors of the Company, according to the terms of item 4.8 of the New Market Regulation, has opined favorably regarding the Tender Offer, pursuant to the prior resolution passed in a meeting held on this date.
The Board of Directors of the Company recommends that the shareholders read the referred prior substantiate opinion and all the publicly available documents, and alerts that each shareholder is responsible for its own final decision regarding the acceptance or the rejection of the Tender Offer.
The minutes of the meeting of the Board of Directors and the complete version of the prior opinion mentioned above are available on the headquarters and on the website of the Company (www.dasa3.com.br), as well as on the website of CVM (www.cvm.gov.br).
Barueri, January 11, 2016.
Carlos de Barros Jorge Neto
Chief Investors Relations OfficerDASA - Diagnósticos da América SA issued this content on 2016-01-14 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-14 19:39:13 UTC
